What Are Expectations For Ginkgo Bioworks Holdings Inc (NYSE: DNA) In The Short Term?

Ginkgo Bioworks Holdings Inc (NYSE:DNA) traded at $0.99 at close of the session on Monday, April 29, made an upward move of 15.08% on its previous day’s price.

Looking at the stock we see that its previous close was $0.86. In terms of its 52-week price range, DNA has a high of $2.55 and a low of $0.74. The company’s stock has lost about -14.67% over that past 30 days.

Ginkgo Bioworks Holdings Inc has a market cap of $2.01 billion. Estimates by analysts give the company expected earnings per share (EPS) of -$0.08, with the EPS growth for the year raised at -$0.32 for 2024 and -$0.27 for next year. These figures represent 30.40% and 15.60% growth in EPS for the two years respectively.

Analysts tracking the company’s growth have also given it a consensus growth in revenue estimated at $46.04 million, with a low of $43 million and a high of $49.93 million. The median projection represents growth adding up to -43.00% compared to sales growth for the corresponding quarter a year ago. According to analyst consensus estimates figures, the company’s yearly revenue forecast for 2024 is expected to hit $223.21 million, or -11.20% down from figures reported last year.

On the other hand, looking at the outlook for the DNA stock, short term indicators assign the stock an average of 50% Sell, while medium term indicators assign it an average of 100% Sell. Long term indicators on average place the stock in the category of 100% Sell.

Looking further, we note the current price level is 1.10% off its SMA20 and -12.98% from its 50-day simple moving average. The RSI (14) is pointing at 49.73 while the volatility over the past week is 15.76% and jumps to 10.15% over the past one month. The beta value is 1.42, while the average true range (ATR) is currently pointing at 0.10.

Coming back to Ginkgo Bioworks Holdings Inc (NYSE:DNA), we note that the average 3-month trading volume was 26.60 million. Current shares outstanding are 1.53 billion.

The insiders hold 33.65% of the company’s shares while institutions hold 60.98%. Investors should be excited about this stock as its upside potential is great, with current price pushing the stock -41.43% down in year-to-date price movement.

Most Popular